Buprenorphine Tablet
Product Images NDC 58118-4459

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-4459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Close-up Of A Labelai-generated Content May Be Incorrect. (Buprenorphine Label 2mg)

Close-up Of A Labelai-generated Content May Be Incorrect. (Buprenorphine Label 2mg)
This text provides information on a package of 255 Buprenorphine SL 2mg tablets in a quantity of 30. It includes details such as the NDC number, expiration date, batch number, manufacturer (Sun Pharmaceutical Industries), and location (Cranbury, NJ, USA). Additionally, the text mentions a repackaging by Ciricl St W LLC. The address of Mery Lindsay Pok DR in Franklin, Tennessee, is also visible.*
FDA Label Image

Buprenorphine-str (Buprenorphine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.